KY
Kymera
KYMR·NASDAQWatertown MAFounded 2016250 employees
Mid CapbiotechPublicOncologyImmunology
Platform: TPD
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (KYMR)
Loading KYMR stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talazasiran | KYM-1258 | NDA/BLA | 1 | MET | HSNB | ||
| KYM-8808 | KYM-8808 | Phase 1/2 | 2 | TIGIT | AS | ||
| Elracapivasertib | KYM-605 | Phase 3 | 1 | PRMT5 | Pancreatic CaDMD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)